Aim: High-sensitivity flow cytometry (FC) allows multiparametric analysis of nanoparticles (NPs) and extracellular vesicles (EVs). With new instruments available, studies that evaluate their performance using the same materials in a controlled environment are required. Here, we performed a comparative study to investigate the capabilities of three flow cytometers, the NanoFCM (NF), BD Influx (IF) and CytoFLEX LX (CF).
Methods: Firstly, we analyzed a mixed population of silica NPs (SiNPs, 68, 91, 113 and 155 nm) by using light-scatter-based detection thresholds [side scatter (SSC), forward scatter (FSC), violet side scatter (VSSC)] across a concentration range from 106 to 109 particles/mL. Next, we analyzed fluorescent recombinant EVs (rEVs) by comparing light-scatter-based thresholding (488 nm SSC available for all platforms), the combination of SSC thresholding with a fluorescent gate, and fluorescent thresholding.
Results: Upon qualitative and quantitative analysis, we observed that instruments differed in sensitivity, the NF could detect 68 nm SiNPs, while both IF and CF were able to detect down to 91 nm SiNPs when using a scatter-based threshold, which was improved by using FSC and VSSC compared to SSC, respectively. We show that the NF required a higher sample concentration to ensure optimal detection, while IF and CF benefited from more diluted samples. Next, we defined a single particle detection range measuring fluorescent rEV and demonstrated that fluorescence-based detection improved the detection of particles of interest due to lower background interference.
Conclusion: We here provide the strengths and limitations for each platform regarding the analysis of differently sized NPs at different sample concentrations.
E. Lozano-Andrés, Ye Tian, S. Libregts et al.· Extracellular Vesicles and C...· 0 citations
The convergence of biosensing and nucleic acid (NA) nanotechnology represents an opportunity for the development of diagnostic technologies. By harnessing the programmability of nucleic acids, we can design biosensors that offer advantages in stability, scalability, versatility and sensitivity, compared to protein-based systems. In this work we introduce DNA-FLASH (DNA-based FLuorescence Amplification upon Single-target Hybridization), a DNA nanosensor concept for digital biosensing. DNA-FLASH leverages fluorescence amplification by a multicomponent NA enzyme (MNAzyme)-driven DNA walker mechanism on a DNA origami disk. Using super-resolution microscopy and single-molecule photobleaching, we demonstrate reproducible fabrication of DNA-FLASH nanosensors with 12 fluorophore-quencher substrates on a ring-shaped track, surrounding a single MNAzyme walker. This nanoarchitecture enables single-molecule detection of DNA targets down to picomolar concentrations. Through precise patterning of DNA-FLASH nanosensors in arrays on glass, we facilitate high-throughput single-molecule readout. We successfully demonstrate DNA-FLASH in human plasma samples and on an in-house developed, fully integrated, self-powered, disposable microfluidic chip, highlighting its potential use in point-of-care settings. Altogether, DNA-FLASH may support the development of next-generation biosensors capable of addressing pressing global challenges, including rapid disease detection, environmental sustainability, and personalized healthcare.